Ginkgo Bioworks (US:DNA) Prnewswire·2026-01-13 13:00Core Insights - Ginkgo Bioworks' Co-Founder and CEO Jason Kelly will present at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026 [1] Company Overview - Ginkgo Bioworks specializes in engineering biology, providing customizable R&D solutions including protein engineering, nucleic acid design, and cell-free systems to accelerate innovation in therapeutics, diagnostics, and manufacturing [2] - The company offers modular laboratory automation through Ginkgo Automation, allowing scientists to focus on planning and analyzing experiments rather than manual pipetting [2] - Ginkgo Datapoints utilizes in-house automation to generate large lab datasets that support AI model development [2] - Ginkgo Biosecurity is focused on creating next-generation infrastructure and technologies for predicting, detecting, and responding to biological threats [2]